Search results
__symbol__ Stock Quote Price and Forecast | CNN
CNN.com· 6 days agoView Zoetis, Inc. Class A ZTS stock quote prices, financial information, real-time forecasts, and company news from CNN.
Elixirgen Scientific Launches Advanced hiPSC-Derived Disease Panel for Alzheimer’s Disease
PharmiWeb· 6 days agoBALTIMORE, MD / ACCESSWIRE / July 16, 2024 / Elixirgen Scientific, Inc., a biotechnology leader focused on advancing drug discovery and revolutionizing ...
Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared
PharmiWeb· 7 days agoMIAMI, FL / ACCESSWIRE / July 15, 2024 / MIRA Pharmaceuticals, Inc. (Nasdaq:MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical development ...
Modular Medical Announces Proof-of-Concept Study for Personalized Metabolic Therapy utilizing the MO
PharmiWeb· 7 days agoSAN DIEGO, CA / ACCESSWIRE / July 15, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology < ...
Champions Oncology Reports Quarterly Revenue of $14.0 Million
PharmiWeb· 4 days agoHACKENSACK, NJ / ACCESSWIRE / July 18, 2024 / Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, today announced ...
AbTherx Appoints Pallavi Tawde, PhD, as Head of Preclinical R&D Strategy
PharmiWeb· 5 days agoFOSTER CITY, CA / ACCESSWIRE / July 17, 2024 / AbTherx, a biotechnology company with innovative technologies that enable and accelerate therapeutic antibody discovery ...
Here’s Why Tyler Technologies (TYL) Surged in Q2
Insider Monkey via Yahoo Finance UK· 6 days agoArtisan Partners, an investment management company, released its “Artisan Mid Cap Fund” second quarter 2024 investor letter. A copy of the letter can be...
Apple’s quest for documents from litigation funder Omni sparks venue fight
Reuters· 5 days agoCritics of litigation funding have been agitating for years for new federal rules that would require...
Global Oncology Blood Testing Market Poised for Unprecedented Growth with a projected rise to USD 18
PharmiWeb· 5 days agoThe global oncology blood testing market is on the brink of extraordinary expansion, with forecasts predicting a remarkable surge from USD 3,851.7 million in 2022 to an estimated USD 18,278.2 ...
Global Reverse Transcriptase Enzymes Market Set for Significant Growth, Projected to Reach USD 481.8
PharmiWeb· 4 days agoAccording to recent market analysis, the sector, valued at USD 335.0 million in 2022, is expected to reach USD 481.8 million by 2032, growing at a CAGR of 3.4%. Reverse transcriptase enzymes ...